Nanotechnology 101: Science, Technology and Health

Wednesday, March 12, 2008, Rayburn House Office Building 2325

Introductory Remarks

Dr. John R. "Jack" Fowle III
Treasurer-Elect of Society for Risk Analysis
Acting Director, Neurotoxicology Division
National Health & Environmental Effects Research Laboratory
U.S. Environmental Protection Agency

Briefing Summary

Nanotechnology has moved from a laboratory curiosity to myriad practical applications in many fields. From new methods of cancer treatment to protecting skin from harmful rays, commercial applications of nanotechnology now improve people's lives. Scientists and engineers continue to discover ways these tiny materials can make better products and cleaner, safer production processes. In hand with the excitement over the new technology is concern about unknown impacts on human and environmental health. A congressional briefing, entitled "Nanotechnology 101: Science, Technology and Health," was held on March 12, 2008, to explore the science and promise of nanoscale materials and the human and environmental health risks.

This briefing, the 123rd briefing in the ACS Science & the Congress series, was sponsored jointly by the American Chemical Society, the Society of Toxicology, and the Society for Risk Analysis. These three organizations collectively represent nearly 170,000 scientists and engineers, including the experts in the U.S. and around the world most familiar with toxicological risk and the regulation of chemical substances and processes.

Briefing Sponsor

The ACS Science & the Congress Project in conjunction with the Society of Toxicology and the Society for Risk Analysis

Featured Speakers

Act4Chemistry.org Blog entry – discuss this briefing

Contact Science & The Congress Briefing Series